Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex

Journal of Neural Transmission

Volumn 108, Issue 12, 2001, Pages 1363-1374

  Li, H ^a   Dryhurst, G ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

5 S cysteinyldopamine; DHBT 1; Parkinson's disease; Pyruvate dehydrogenase complex

Indexed keywords

5 SULFURCYSTEINYLDOPAMINE; 7 (2 AMINOETHYL) 3,4 DIHYDRO 5 HYDROXY 1,4 BENZOTHIAZINE 3 CARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; CYSTEINE; DOPAMINE DERIVATIVE; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COVALENT BOND; ENZYME INHIBITION; MALE; METABOLITE; NONHUMAN; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ASCORBIC ACID; CATALASE; DOPAMINE; ENERGY METABOLISM; GLUTATHIONE; INTRACELLULAR MEMBRANES; MALE; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; PYRUVATE DEHYDROGENASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE; THIAZINES;

EID: 0035659572     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020100013     Document Type: Article

References (34)

1. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
2. Identification of the essential cysteine residue in the active site of bovine pyruvate dehydrogenase
3. The respiration of brain mitochondria and its regulation by monovalent cation transport
4. The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence
5. Monoamine oxidase, hydrogen peroxide and Parkinson's disease
6. Role of astrocytes in maintaining cerebral glutathione homeostasis and protecting the brain against xenobiotics and oxidative stress
7. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
8. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra
9. Protein nitration in Parkinson's disease
10. Biochemical pathophysiology of Parkinson's disease
11. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
12. Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders
13. Inhibition of peroxynitrite-mediated oxidation of dopamine by flavonoid and phenolic antioxidants and their structural relationships
14. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: Pathophysiologic and clinical implications
15. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1): A putative nigral endotoxin of relevance to Parkinson's disease
16. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: Potential relevance to the pathogenesis of Parkinson's disease
17. An immunohistochemical study α-ketoglutarate dehydrogenase complex in Parkinson's disease
18. Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease
19. Alterations in the distribution of glutathione in the substantia nigra of Parkinson's disease
20. Biochemical localization of γ-glutamyl transpeptidase within cellular elements of the rat cerebral cortex
21. A selective increase in particulate superoxide dismutase activity in the parkinsonian substantia nigra
22. Mitochondrial complex I deficiency in Parkinson's disease
23. Anatomic and disease specificity of NADH-CoQ1 reductase (complex I) deficiency in Parkinson's disease
24. Alpha-keto acid dehydrogenase complexes. 13. Reaction of sulfhydryl groups in pyruvate dehydrogenase with organic mercurials
25. Glutathione biosynthesis: γ-glutamylcysteine synthetase from rat kidney
26. Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: Reaction pathways of potential relevance to Parkinson's disease
27. Oxidative metabolites of 5-S-cysteinyldopamine inhibit α-ketoglutarate dehydrogenase complex: Possible relevance to the pathogenesis of Parkinson's disease
28. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia
29. Glutathione related enzymes in brain in Parkinson's disease
30. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
31. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease. Possible mechanisms of formation involving reactive oxygen species
32. Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase
33. γ-glutamyl transpeptidase from kidney